Nanocurcumin improves cellular viability under hypoxia:

<p>(A) Hypoxia insult caused decline in cell viability (20%) compared to normoxia control cells by 24 h. (B) Nanocurcumin treatment at 500 ng/ml significantly improved cellular viability (89%) by 24 h of hypoxia exposure and confirmed by FACS. Curcumin treatment did not show significant improvement in cellular viability at any time point. No significant change in cell viability was observed in nanocurcumin or curcumin treated cells under normoxia. Nanocurcumin treatment at 500 ng/ml was used for further experiments. Values are mean ± SD, significant values represented as ^@@p≤0.01 <i>vs</i> normoxia and ^#p≤0.01 <i>vs</i> hypoxia. Non-significant changes are designated as ns.